In the management of pain due to visceral malignancy (especially pancreatic carcinoma) in adults, neurolytic celiac plexus blockade has emerged as an effective pain management procedure1,2; in the management of severe pain due to pancreatic carcinoma, it is regarded by many as the technique of choice.3 In this procedure, a nerve-destructive agent such as ethanol or phenol is injected percutaneously, usually from a posterolateral approach, immediately around the aorta and vena cava at the level of origin of the celiac artery. When performed for pancreatic cancer pain, celiac blockade provides good or excellent pain relief in 85% to 97% of cases, generally for 6 months to 2 years.

This content is only available via PDF.
You do not currently have access to this content.